U.S. Stock Insider Trading | Viatris Disclosed 14 Insider Transactions on March 10

K-LinePoet · 2026-03-23T23:37:36+00:00

On March 10, 2026, Viatris disclosed 14 insider transactions, including director Smith Scott Andrew selling 51,400 shares on March 6. Viatris is a global healthcare company committed to meeting the health needs of patients worldwide.

K-LinePoet

2026-03-23 23:37:36

Abstract generation in progress

On March 10, 2026, Viatris (VTRS) disclosed 14 insider transactions. Director Smith Scott Andrew sold 49,000 shares on March 6, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
March 10, 2026	Executive	Campbell Paul	March 6, 2026	Sell	12,700	14.16	$179,700
March 10, 2026	Executive	Mistras Theodora	March 6, 2026	Sell	24,200	14.16	$342,900
March 10, 2026	Director	Groothuis Leo Frans	March 6, 2026	Sell	1,305	14.16	$18,500
March 10, 2026	Director	Smith Scott Andrew	March 6, 2026	Sell	51,400	14.16	$728,300
March 10, 2026	Executive	Enrietti Andrew	March 6, 2026	Sell	8,752	14.16	$123,900
March 10, 2026	Executive	Le Goff Corinne	March 6, 2026	Sell	20,600	14.16	$291,100
March 10, 2026	Director	SIMMONS DAVID S	August 27, 2025	Buy	286	10.42	$2,980.98
March 10, 2026	Director	SIMMONS DAVID S	November 3, 2025	Buy	213	10.43	$2,220.63
March 5, 2026	Director	Smith Scott Andrew	March 3, 2026	Sell	567,000	14.89	$8,442,200
March 5, 2026	Director	Smith Scott Andrew	March 4, 2026	Sell	39,800	14.71	$585,900

[Company Profile]

Viatris Inc. was incorporated in Delaware on February 14, 2019. The company is a global healthcare organization that believes it has a unique positioning to bridge the traditional gap between generics and branded drugs, combining the advantages of both to better meet healthcare needs worldwide. Viatris’s mission is to empower people around the world to live healthier lives at every stage of life by providing broad access to high-quality medicines. Currently, the company supplies high-quality medicines to approximately one billion patients globally each year, touching all moments of life—from birth to end-of-life, from acute to chronic conditions.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.